SPINA-GR

Uses your system voice; voice and rate in settings.

Snapshot

≈ 3 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

SPINA-GR is a calculated biomarker for insulin sensitivity. It represents insulin receptor gain. The method of calculation is based on a time-discrete nonlinear feedback model of insulin-glucose homeostasis that is rooted in the MiMe-NoCoDI modeling platform for endocrine systems.

SPINA-GR is a calculated biomarker for insulin sensitivity. It represents insulin receptor gain. The method of calculation is based on a time-discrete nonlinear feedback model of insulin-glucose homeostasis that is rooted in the MiMe-NoCoDI modeling platform for endocrine systems.

How to determine G R

The index is derived from a mathematical model of insulin-glucose homeostasis that incorporates fundamental physiological motifs. For diagnostic purposes, it is calculated from fasting insulin and glucose concentrations with: {\widehat{G}}_{R}=\frac{{G}_{1}P(\infty )({D}_{R}+\left[I\right](\infty ))}{{G}_{E}\left[I\right](\infty )[G](\infty )}-\frac{{D}_{R}}{{G}_{E}[I](\infty )}-\frac{1}{{G}_{E}} .

[I](∞): Fasting Insulin plasma concentration (mol/L) [G](∞): Fasting blood glucose concentration (mol/L) G 1 : Parameter for pharmacokinetics (154.93 s/L) D R : EC 50 of insulin at its receptor (1,6 nmol/L) G E : Effector gain (50 s/mol) P(∞): Constitutive endogenous glucose production (150 μmol/s)

Validity

Compared to healthy volunteers, SPINA-GR is significantly reduced in persons with prediabetes and diabetes mellitus, and it correlates with the M value in glucose clamp studies, triceps skinfold, subscapular skinfold and (better than HOMA-IR and QUICKI) with the two-hour value in oral glucose tolerance testing (OGTT), glucose rise in OGTT, waist-to-hip ratio, body fat content (measured via DXA) and the HbA1c fraction.

Clinical utility

Both in the FAST study, an observational case-control sequencing study including 300 persons from Germany, and in a large sample from the NHANES study, SPINA-GR differed more clearly between subjects with and without diabetes than the corresponding HOMA-IR, HOMA-IS and QUICKI indices.

Pathophysiological implications

In lean subjects it is significantly higher than in a population with obese persons. In several populations, SPINA-GR correlated with the area under the glucose curve and 2-hour concentrations of glucose, insulin and proinsulin in oral glucose tolerance testing, concentrations of free fatty acids, ghrelin and adiponectin, and the HbA1c fraction.

SPINA-GR declines with increasing adherence to mediterranean diet , which may be explained by increased use of other macronutrients for energy production. In mice, SPINA-GR is reduced after they were fed a high-fat diet for one and three weeks . In hidradenitis suppurativa, an inflammatory skin disease, SPINA-GR is reduced.

If this state is uncompensated by increased beta-cell function the static disposition index (SPINA-DI) is reduced, resulting in the onset of diabetes mellitus.

Predictive aspects

In a longitudinal evaluation of the NHANES study, a large sample of the general US population, over 10 years, reduced SPINA-DI, calculated as the product of SPINA-GBeta times SPINA-GR, significantly predicted all-cause mortality.

Software for calculating SPINA-GR and other parameters for endotyping glucose homeostasis. (Permanent DOI), (General information and US mirror) Functions for R and S for calculating SPINA-GBeta, SPINA-GR and SPINA-DI. (Permanent DOI) Package "SPINA" for the statistical environment R

Text derived from https://en.wikipedia.org/w/index.php?oldid=1377484451 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

2 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.